187 related articles for article (PubMed ID: 17904728)
1. When and how to treat superficial and muscle-invasive bladder cancer.
Zlotta AR
Eur Urol; 2007 Dec; 52(6):1554-7. PubMed ID: 17904728
[No Abstract] [Full Text] [Related]
2. [Organ-preserving therapy of muscle-invasive bladder carcinoma].
Hartung R; Block T
Dtsch Med Wochenschr; 1992 Nov; 117(47):1818. PubMed ID: 1425310
[No Abstract] [Full Text] [Related]
3. Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments.
Parekh DJ; Bochner BH; Dalbagni G
J Clin Oncol; 2006 Dec; 24(35):5519-27. PubMed ID: 17158537
[TBL] [Abstract][Full Text] [Related]
4. Multimodality bladder preservation therapy for muscle-invasive bladder tumors.
Fernando SA; Sandler HM
Semin Oncol; 2007 Apr; 34(2):129-34. PubMed ID: 17382796
[TBL] [Abstract][Full Text] [Related]
5. The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer.
deVere White RW; Katz MH; Steinberg GD
J Urol; 2009 May; 181(5):1994-7. PubMed ID: 19286209
[No Abstract] [Full Text] [Related]
6. Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.
Milowsky MI; Stadler WM; Bajorin DF
BJU Int; 2008 Nov; 102(9 Pt B):1339-44. PubMed ID: 19035902
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and clinical outcomes of patients with node-positive muscle-invasive bladder cancer.
Bruins HM; Stein JP
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1091-101. PubMed ID: 18588454
[TBL] [Abstract][Full Text] [Related]
8. Ongoing trials in bladder cancer conducted by the EORTC Genito-Urinary Tract Cancer Cooperative Group.
De Pauw M
Prog Clin Biol Res; 1988; 260():215-23. PubMed ID: 3283760
[No Abstract] [Full Text] [Related]
9. Total cystectomy versus bladder preservation therapy for locally invasive bladder cancer: effect of combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.
Azuma H; Yamamoto K; Inamoto T; Ibuki N; Kotake Y; Sakamoto T; Kiyama S; Ubai T; Takahara K; Segawa N; Narumi Y; Katsuoka Y
Am J Clin Oncol; 2009 Dec; 32(6):592-606. PubMed ID: 19593084
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S
Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
[TBL] [Abstract][Full Text] [Related]
11. Risk of concomitant carcinoma in situ determining biopsy candidates among primary non-muscle-invasive bladder cancer patients: retrospective analysis of 173 Japanese cases.
Hara T; Takahashi M; Gondo T; Nagao K; Ohmi C; Sakano S; Naito K; Matsuyama H
Int J Urol; 2009 Mar; 16(3):293-8. PubMed ID: 19207607
[TBL] [Abstract][Full Text] [Related]
12. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
[TBL] [Abstract][Full Text] [Related]
13. How I treat invasive bladder carcinoma.
Camey M
Prog Clin Biol Res; 1984; 162B():231-5. PubMed ID: 6504898
[No Abstract] [Full Text] [Related]
14. [Treatments in invasive bladder cancer].
Bouchot O; Zerbib M
Prog Urol; 2003 Dec; 13(6):1415-27. PubMed ID: 15000325
[TBL] [Abstract][Full Text] [Related]
15. Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
Witjes JA
Eur Urol; 2009 Apr; 55(4):919. PubMed ID: 18722044
[No Abstract] [Full Text] [Related]
16. Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
Herr HW
Eur Urol; 2009 Apr; 55(4):920-1. PubMed ID: 18722043
[No Abstract] [Full Text] [Related]
17. Response criteria for phase III studies of superficial bladder cancer.
Schröder FH; Sylvester R; Gustafson H; Kawai T; Kurth KH; Matsuda M; Miyakawa M; Newling DW; Studer E
Prog Clin Biol Res; 1986; 221():311-21. PubMed ID: 3543946
[No Abstract] [Full Text] [Related]
18. [Possibilities and limits of curative and palliative therapy of muscle invasive bladder cancers].
Hofmann W; Langkopf B
Z Urol Nephrol; 1987 Jul; 80(7):413-24. PubMed ID: 2444041
[No Abstract] [Full Text] [Related]
19. Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy.
Weiss C; Wittlinger M; Engehausen DG; Krause FS; Ott OJ; Dunst J; Sauer R; Rödel C
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1502-6. PubMed ID: 17935905
[TBL] [Abstract][Full Text] [Related]
20. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis.
Koga F; Yoshida S; Kawakami S; Kageyama Y; Yokoyama M; Saito K; Fujii Y; Kobayashi T; Kihara K
Urology; 2008 Aug; 72(2):384-8. PubMed ID: 18455771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
